Resveratrol: Biological and pharmaceutical properties as anticancer molecule
- 7 July 2010
- journal article
- review article
- Published by Wiley in BioFactors
- Vol. 36 (5), 360-369
- https://doi.org/10.1002/biof.105
Abstract
There is ample evidence that shows an inverse relationship between consumption of fruit/vegetable‐rich diets and the risk of cancer at various anatomical sites. In this review, we will assess and summarize recent advances on cancer prevention by resveratrol, a natural stilbenoid present in red grapes, peanuts, some common drinks, and dietary supplements. We will focus on data published within the past few years on in vivo model tumor animal studies that reinforce the chemopreventive efficacy of resveratrol against a multitude of cancers, as well as on its sensitization/enhancing activities against tumor cells when used in combination with established chemotherapeutic and pharmaceutical agents. In addition, we will review examples resveratrol‐target proteins, denoted RTPs, including the 24‐kDa cytosolic protein quinone reductase 2 (NQO2) discovered in our laboratory that may confer resveratrol responsiveness to cancer cells. We will discuss the possible role of NQO2 in mediating cancer prevention by resveratrol. Our analysis of published data strengthen support that resveratrol displays novel roles in various cellular processes, and help to establish an expanded molecular framework for cancer prevention by resveratrol in vivo.Keywords
This publication has 96 references indexed in Scilit:
- Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells invitro and in vivoEuropean Journal of Cancer, 2010
- Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancerInternational Journal of Cancer, 2009
- Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV‐40 tag ratsThe Prostate, 2009
- Resveratrol enhances cell‐mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesisMolecular Carcinogenesis, 2009
- Quinone reductase acts as a redox switch of the 20S yeast proteasomeEMBO Reports, 2008
- Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2Biochemical Journal, 2008
- Resveratrol directly targets COX‐2 to inhibit carcinogenesisMolecular Carcinogenesis, 2008
- Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivoCarcinogenesis: Integrative Cancer Research, 2008
- A scientific journey through the 2-5A/RNase L systemCytokine & Growth Factor Reviews, 2007
- Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsNature Biotechnology, 2007